CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
research
Upregulated expression of the growth arrest-specific-2 (gas2) gene in colorectal cancer, and its relation to cancer progression and prognosis
Authors
G. Basati
S. Bastaminejad
B. Izadi-Ajeerlo
Publication date
1 January 2019
Publisher
Doi
Cite
Abstract
Background: Growth arrest-specific 2 (GAS2) gene is implicated in a variety of cellular functions such as cell cycle, apoptosis, and proliferation, and may be potentially involved in cancer progression. However, whether GAS2 is associated with colorectal cancer (CRC) progression and prognosis remains to be uncovered. Thus, this study investigated the association of GAS2 expression in tumor with CRC progression and prognosis. Methods: In the case-control study, surgical tumor and adjacent normal tissues from 40 patients with CRC were collected at Cancer Institute of Imam Khomeini Hospital in Tehran, Iran, and relative expression level of GAS2 in the tissues was assayed using quantitative real-time polymerase chain reaction method. The correlation of tumor GAS2 expression with the clinicopathological features and overall survival rate of patients was determined. Findings: The relative expression level of GAS2 in tumor tissues was significantly elevated compared to the adjacent normal tissues 1.96 (1.17-3.40) vs. 1.10 (1.00-1.31), P < 0.001. Moreover, the expression levels of GAS2 in tumor tissues were significantly associated with clinicopathological features of cancer including tumor stage in Tumor spread, Lymph node spread, and Metastasis (TNM) staging (P = 0.010), grade (P = 0.010), size (P = 0.030), and lymphatic (P = 0.030) and vascular invasion (P = 0.040) as well as the decreased overall survival (P = 0.040). Conclusion: Elevated expression of GAS2 in CRC is associated with cancer progression indices and poor prognosis; hence it may be served as a prognostic biomarker in CRC. © 2019, Isfahan University of Medical Sciences(IUMS). All rights reserved
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Research Repository Portal of Medilam
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.medilam.ac.ir:2495
Last time updated on 26/03/2018